Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value

T Moser (Erstautor/-in), M Seiberl (Letztautor/-in)

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

1 Quellenangabe (Web of Science)

Zugriff auf Dokument

@article{047bb8a6a8a5409ebdce5f83d702d96c,

title = "Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value",

author = "T Moser and M Seiberl",

note = "beide: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Center for Cognitive Neuroscience",

year = "2023",

month = apr,

day = "25",

doi = "10.1212/WNL.0000000000202728",

language = "English",

volume = "100",

journal = "NEUROLOGY ",

issn = "0028-3878",

publisher = "Lippincott Williams & Wilkins ",

number = "17",

}

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value

AU - Moser, T

AU - Seiberl, M

N1 - beide: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Center for Cognitive Neuroscience

PY - 2023/4/25

Y1 - 2023/4/25

U2 - 10.1212/WNL.0000000000202728

DO - 10.1212/WNL.0000000000202728

M3 - Abstract (Journal)

SN - 0028-3878

VL - 100

JO - NEUROLOGY

JF - NEUROLOGY

IS - 17

M1 - 2694

ER -